Remove tag long-term-treatment
article thumbnail

Cost of disease-modifying therapies for multiple sclerosis continues to rise in US

Pharmaceutical Technology

Currently, most patients face the prospect of life-long treatment with MS medications, as the main objectives of available disease-modifying therapies (DMTs) are to reduce the frequency of relapses and to delay the accumulation of disability. DMTs for MS have a high price tag, particularly in the US.

98
article thumbnail

Free access to Zolgensma curbed, says Novartis

pharmaphorum

Since 2020, the global SMA treatment landscape has progressed, with three treatments now approved, according to Novartis. ” Zolgensma is one of the most expensive therapies available, with a price tag of around $2.1 ” Zolgensma is one of the most expensive therapies available, with a price tag of around $2.1

119
119
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A broad range of unmet needs remains in the immuno-oncology space

Pharmaceutical Technology

Immuno-oncology (IO) agents have transformed the cancer therapeutics landscape, driving long-term remissions in a subset of patients who historically had limited options. Efficacy-related unmet needs included the need for a greater long-term benefit, higher response rates, and mechanisms for overcoming resistance to IO therapies.

article thumbnail

What causes armpit pain? Related conditions and treatments

The Checkup by Singlecare

There’s not a one-size-fits-all treatment,” says Jay W. Read more about treatments for skin tags , hidradenitis suppurativa , and shingles. Growths “Growths such as cysts, skin tags, and moles can also cause pain when they’re inflamed,” says Brendan Camp, MD , a dermatologist with MDCS Dermatology in New York.

article thumbnail

Orphan drugs’ financial success raises questions

pharmaphorum

R&D into orphan drugs is growing alongside the number of approved treatments, providing treatments for rare diseases that previously did not have any. As covered in a previous article , the importance of R&D to develop treatments for rare diseases is high. It is estimated that between 3.5 The price is right.

article thumbnail

4 benefits of GLP-1 drugs

The Checkup by Singlecare

More people need treatment for obesity: The rise in obesity rates parallels the rise of GLP-1 prescriptions. Currently, the only GLP-1s that are FDA approved for chronic weight management in people without diabetes are Wegovy (semaglutide) and Saxenda (liraglutide)—as long as patients meet certain criteria. in 1999-2000 to 41.9%

article thumbnail

Hydrocodone acetaminophen alternatives: What can I take instead of hydrocodone acetaminophen?

The Checkup by Singlecare

Opioids should not be used as first-line therapy for short-term or chronic pain —with the exception being in end-of-life or palliative care, during active cancer treatment, and with sickle cell disease. Belbuca is a good alternative to opioid treatment that needs to be taken around the clock, but it may come with a hefty price tag.

Dosage 52